SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results
Rhea-AI Summary
SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of FDA-approved wound care products, has announced a live conference call scheduled for August 13, 2024, at 8:30 AM (ET) to present their Q2 2024 financial results. Investors can access the call via toll-free (1-800-579-2543) or international (1-785-424-1789) numbers using the Conference ID: SANUWAVE. Alternatively, instant telephone access is available through a provided link.
Conference materials will be accessible on the company's website. A replay of the call will be available until September 3, 2024, using specific replay access numbers and ID. This event provides an opportunity for stakeholders to gain insights into SANUWAVE's recent financial performance and future outlook.
Positive
- SANUWAVE is proactively communicating with investors by hosting a conference call to discuss Q2 2024 financial results
- The company is providing multiple access options for the call, including toll-free and international numbers, as well as an instant access link
- A replay of the call will be available for an extended period, allowing investors to review the information at their convenience
Negative
- None.
EDEN PRAIRIE, MN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Tuesday, August 13, 2024, at 8:30 AM (ET) to present the Q2 2024 financial results.
Telephone access to the call will be available by dialing the following numbers:
Participant Dial-in Information
Toll Free: 1-800-579-2543
Toll/International: 1-785-424-1789
Conference ID: SANUWAVE
OR click the link for instant telephone access to the event.
https://viavid.webcasts.com/starthere.jsp?ei=1684060&tp_key=35ff7216a3
Materials for the conference call will be included on the Company’s website at www.sanuwave.com/investors.
A replay will be made available through September 3, 2024:
Toll-Free: 1-844-512-2921 or 1-412-317-6671
Replay Access ID: 11156749
About SANUWAVE
SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations and constraints, and plans for future business development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with supply chain and production constraints, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
investors@sanuwave.com
FAQ
When will SANUWAVE Health (SNWV) host its Q2 2024 financial results conference call?
How can investors access SANUWAVE's (SNWV) Q2 2024 financial results conference call?
Until what date will the replay of SANUWAVE's (SNWV) Q2 2024 financial results call be available?
Where can investors find materials for SANUWAVE's (SNWV) Q2 2024 financial results conference call?
